首页> 美国卫生研究院文献>Gastroenterology Research and Practice >Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte dIvoire (West Africa)
【2h】

Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte dIvoire (West Africa)

机译:在科特迪瓦(西非)的非洲黑人肝硬化患者中食管静脉曲张无创预测指标的实用性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aims. To determine the usefulness of platelet count (PC), spleen diameter (SD) and platelet count/spleen diameter ratio (PC/SD ratio) for the prediction of oesophageal varices (OV) and large OV in black African patients with cirrhosis in Côte d'Ivoire. Materials and Methods. Study was conducted in a training sample (111 patients) and in a validation sample (91 patients). Results. Factors predicting OV were sex: (OR = 0.08, P = 0.0003), PC (OR = 12.4, P = 0.0003), SD (OR = 1.04, P = 0.002) in the training sample. The AUROCs (±SE) of the model (cutoff ≥ 0.6), PC (cutoff < 110500), SD (cutoff > 140) and PC/SD ratio (cutoff ≤ 868) were, respectively; 0.879 ± 0.04, 0.768 ± 0.06, 0.679 ± 0.06, 0.793 ± 0.06. For the prediction of large OV, the model's AUROC (0.850 ± 0.05) was superior to that of PC (0.688 ± 0.06), SD (0.732 ± 0.05) and PC/SD ratio (0.752 ± 0.06). In the validation sample, with PC, PC/SD ratio and the model, upper digestive endoscopy could be obviated respectively in 45.1, 45.1, and 44% of cirrhotic patients. Prophylactic treatment with beta blockers could be started undoubtedly respectively in 36.3, 41.8 and 28.6% of them as having large OV. Conclusion. Non-invasive means could be used to monitor cirrhotic patients and consider treatment in African regions lacking endoscopic facilities.
机译:目的为了确定血小板计数(PC),脾脏直径(SD)和血小板计数/脾脏直径比(PC / SD比)对预测非洲科特迪瓦黑人肝硬化患者的食道静脉曲张(OV)和大OV的有用性'象牙。材料和方法。在训练样本(111例患者)和验证样本(91例患者)中进行了研究。结果。预测OV的因素是性别:训练样本中的性别(OR = 0.08,P = 0.0003),PC(OR = 12.4,P = 0.0003),SD(OR = 1.04,P = 0.002)。模型的AUROC(±SE)(截止值≥0.6),PC(截止值<110500),SD(截止值> 140)和PC / SD比(截止值≤868)分别是; 0.879±0.04、0.768±0.06、0.679±0.06、0.793±0.06对于大OV的预测,模型的AUROC(0.850±0.05)优于PC(0.688±0.06),SD(0.732±0.05)和PC / SD比(0.752±0.06)。在验证样本中,通过PC,PC / SD比和模型,分别可在45.1%,45.1%和44%的肝硬化患者中消除上消化内镜检查。毫无疑问,使用β受体阻滞剂的预防性治疗可在OV大的情况下分别开始于36.3、41.8和28.6%。结论。非侵入性手段可用于监测肝硬化患者并考虑在缺乏内镜设施的非洲地区进行治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号